Biogen Announces $5.6 Billion Takeover of Apellis, Expanding Rare‑Disease Portfolio
🎧 Listen:By Connor Hart | March 31, 2026Biogen’s $5.6 B Acquisition of Apellis Aims to Supercharge Rare‑Disease Innovation Deal value of ...
Tag: Rare Disease
MAHA Is Bringing Chaos to Biotech Investment Beyond Just Vaccines
🎧 Listen:By David Wainer | March 08, 2026MAHA’s Rare-Disease Overhaul Could Fast-Track 300 Drugs for 30 Million AmericansFDA currently lists ...